Toll-like receptor 2-independent and MyD88-dependent gene expression in the mouse brain

Journal of Innate Immunity

Volumn 1, Issue 5, 2009, Pages 480-493

  Naert, Gaëlle ^a   Laflamme, Nathalie ^a   Rivest, Serge ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Chemokines; Cytokines; Inflammation; Innate immunity; Lipopolysaccharide; Microglia; NF B

Indexed keywords

CD14 ANTIGEN; CHEMOKINE; CYTOKINE; ENDOTOXIN; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GRAM POSITIVE BACTERIUM; IMMUNE RESPONSE; IN SITU HYBRIDIZATION; IN VIVO STUDY; INNATE IMMUNITY; MALE; MICROGLIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; WILD TYPE;

ANIMALS; BRAIN; CYTOKINES; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; TOLL-LIKE RECEPTOR 2;

EID: 77953447000     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000225990     Document Type: Article

References (41)

1. Akira S, Uematsu S, Takeuchi, O: Pathogen recognition and innate immunity. Cell 2006;124:783-801.
2. Glezer I, Simard AR, Rivest S: Neuroprotective role of the innate immune system by microglia. Neuroscience 2007;147:867-883.
3. Turrin NP, Rivest S: Molecular and cellular immune mediators of neuroprotection. Mol Neurobiol 2006;34:221-242. (Pubitemid 46268976)
4. Aloisi F: Immune function of microglia. Glia 2001;36:165-179.
5. Olson JK, Miller SD: Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 2004;173:3916-3924.
6. Uematsu S, Akira S: Toll-like receptors and innate immunity. J Mol Med 2006;84:712-725.
7. Uematsu S, Akira S: Toll-like receptors and type I interferons. J Biol Chem 2007;282:15319-15323.
8. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, Akira S: Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998;9:143-150. (Pubitemid 28361303)
9. Kopp E, Medzhitov R: Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol 2003;15:396-401. (Pubitemid 36930075)
10. Takeda K, Akira S: TLR signaling pathways. Semin Immunol 2004;16:3-9.
11. Takeda K, Akira S: Toll-like receptors in innate immunity. Int Immunol 2005;17:1-14.
12. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003;21:335-376.
13. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-397.
14. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-2088. (Pubitemid 29001265)
15. Wright SD: Toll, a new piece in the puzzle of innate immunity. J Exp Med 1999;189:605-609. (Pubitemid 29193360)
16. Kawasaki K, Akashi S, Shimazu R, Yoshida T, Miyake K, Nishijima M: Involvement of TLR4/MD-2 complex in species-specific lipopolysaccharide- mimetic signal transduction by Taxol. J Endotoxin Res 2001;7:232-236. (Pubitemid 32894579)
17. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M: MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999;189:1777-1782. (Pubitemid 29272694)
18. Nadeau S, Rivest S: Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor kappa B activity in the brain during endotoxemia. J Neurosci 2000;20:3456-3468. (Pubitemid 30263162)
19. Nadeau S, Rivest S: Endotoxemia prevents the cerebral inflammatory wave induced by intraparenchymal lipopolysaccharide injection: role of glucocorticoids and CD14. J Immunol 2002;169:3370-3381. (Pubitemid 35013187)
20. Nguyen MD, Julien JP, Rivest S: Innate immunity: the missing link in neuroprotection and neurodegeneration? Nature Rev Neurosci 2002;3:216-227.
21. Glezer I, Lapointe A, Rivest S: Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FASEB J 2006;20:750-752. (Pubitemid 46671203)
22. Laflamme N, Echchannaoui H, Landmann R, Rivest S: Cooperation between toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from Gram-negative and Gram-positive bacteria. Eur J Immunol 2003;33:1127-1138. (Pubitemid 36546701)
23. Laflamme N, Soucy G, Rivest S: Circulating cell wall components derived from Gramnegative, not Gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS. J Neurochem 2001;79:648-657. (Pubitemid 33029938)
24. Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH, Zachary JF, Kirschning CJ, Weis JJ: Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi . J Immunol 2002;168:348-355.
25. Simard AR, Rivest S: Neuroprotective effects of resident microglia following acute brain injury. J Comp Neurol 2007;504:716-729. (Pubitemid 350246584)
26. Paxinos G, Franklin K: The Mouse Brain in Stereotaxic Coordinates, ed 2. San Diego, Academic Press, 2001.
27. Laflamme N, Lacroix S, Rivest S: An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J Neurosci 1999;19:10923-10930. (Pubitemid 30235736)
28. Laflamme N, Rivest S: Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating Gram-negative bacterial cell wall components. FASEB J 2001;15:155-163. (Pubitemid 32061666)
29. Liu Y, Wang Y, Yamakuchi M, Isowaki S, Nagata E, Kanmura Y, Kitajima I, Maruyama I: Upregulation of toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-kappa B activation. Infect Immun 2001;69:2788-2796. (Pubitemid 32332166)
30. Soucy G, Boivin G, Labrie F, Rivest S: Estradiol is required for a proper immune response to bacterial and viral pathogens in the female brain. J Immunol 2005;174:6391-6398. (Pubitemid 40663832)
31. Blais V, Rivest S: Effects of TNF-alpha and IFN-gamma on nitric oxide-induced neurotoxicity in the mouse brain. J Immunol 2004;172:7043-7052. (Pubitemid 38669146)
32. Musikacharoen T, Matsuguchi T, Kikuchi T, Yoshikai Y: NF-kappa B and STAT5 play important roles in the regulation of mouse Tolllike receptor 2 gene expression. J Immunol 2001;166:4516-4524. (Pubitemid 32233736)
33. Faure E, Thomas L, Xu H, Medvedev A, Equils O, Arditi M: Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J Immunol 2001;166:2018-2024. (Pubitemid 32114690)
34. Wang T, Lafuse WP, Zwilling BS: Regulation of Toll-like receptor 2 expression by macrophages following Mycobacterium avium infection. J Immunol 2000;165:6308-6313.
35. Babcock AA, Wirenfeldt M, Holm T, Nielsen HH, Dissing-Olesen L, Toft-Hansen H, Millward JM, Landmann R, Rivest S, Finsen B, Owens T: Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J Neurosci 2006;26:12826-12837. (Pubitemid 44904578)
36. Boivin A, Pineau I, Barrette B, Filali M, Vallieres N, Rivest S, Lacroix S: Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J Neurosci 2007;27:12396-12406. (Pubitemid 350127805)
37. Kigerl KA, Lai W, Rivest S, Hart RP, Satoskar AR, Popovich PG: Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem 2007;102:37-50. (Pubitemid 46906264)
38. O'Neill LA, Bowie AG: The family of five: TIR-domain-containing adaptors in Tolllike receptor signalling. Nat Rev Immunol 2007;7:353-364.
39. Kaisho T, Akira S: Toll-like receptor function and signaling. J Allergy Clin Immunol 2006;117:979-987; quiz 988.
40. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S: Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999;11:115-122.
41. Kawai T, Takeuchi O, Fujita T, Inoue J, Muhlradt PF, Sato S, Hoshino K, Akira S: Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 2001;167:5887-5894. (Pubitemid 33062783)